Related Experiment Video
Updated: Jun 19, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Bowel lesions in spondyloarthritides
M Rimbaş1, Mădălina Marinescu, M R Voiosu
1Gastroenterology Department, Clinic of Internal Medicine, Colentina Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. mrimbas@yahoo.com
Gut inflammation is common in spondyloarthropathies, potentially preceding inflammatory bowel disease. Early gut inflammation treatment may prevent disease progression, though research is complex.
Area of Science:
- Gastroenterology
- Rheumatology
- Immunology
Background:
- Gut inflammation is implicated in rheumatic conditions like spondyloarthropathies.
- Histological gut inflammation affects over 50% of spondyloarthropathy patients.
- Subclinical gut inflammation can evolve into clinical inflammatory bowel disease in 20% of patients.
Purpose of the Study:
- To explore the connection between joint and gut inflammation in spondyloarthropathies.
- To investigate the potential of early gut inflammation treatment to prevent inflammatory bowel disease.
- To understand how medications influence gut inflammation in spondyloarthropathies.
Main Methods:
- Ileocolonoscopic studies to assess histological gut inflammation.
- Observational studies tracking the evolution of gut inflammation in spondyloarthropathy patients.
- Analysis of medication effects (NSAIDs, DMARDs, corticosteroids, biologics) on inflammatory bowel lesions.
Main Results:
- High prevalence of histological gut inflammation in spondyloarthropathy patients.
- Significant progression from subclinical gut inflammation to clinical inflammatory bowel disease.
- Medications can negatively (NSAIDs) or positively (DMARDs, biologics) impact gut lesions.
Conclusions:
- Gut inflammation is a key factor in spondyloarthropathy pathogenesis.
- Early intervention in gut inflammation may prevent progression to inflammatory bowel disease.
- Further research is needed to clarify the complex interplay between spondyloarthropathies, gut inflammation, and treatment strategies.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis

